Home Sitemap Contact us Accessibility Statement Top of the page

Oncology in focus

oncology from Teva

We understand that a diagnosis of cancer often brings with it a lot of anxiety, uncertainty and confusion. We want to be able to support cancer patients on their therapeutic journey.

Cancer is a broad group of diseases where tumours develop, often growing uncontrollably. Unfortunately, tumours can also spread into neighbouring healthy tissue and organs. Some types of cancer respond very well to treatment, and recovery rates are high. For others, the picture is not as positive.

However, there are a wide range of treatment options available, both aiming to reduce tumour size and also to alleviate side effects and other symptoms that can come about as a result of either the cancer itself, or the treatments used.

Each form of cancer has its own specific method of diagnosis and treatment – these include chemotherapy (powerful medication that kills the cancer cells), radiotherapy (using high energy x-rays to kill the cancer cells) and surgery (to remove the affected tissue).

Teva has a wide range of medicines to treat not only cancer, but also the side effects of cancer treatment, like neutropenia (where the number of infection-fighting white blood cells is reduced as a result of chemotherapy), as well as pain which often comes about as a result of the tumour pressing on surrounding tissue, organs or bones, or because of the treatments used to fight the disease. Our cancer medicines are usually prescribed in hospital by a cancer specialist. 

Within Teva's innovative specialty medicines we have Myocet® (doxorubicin), Trisenox® (arsenic trioxide) and Lonquex® (lipegfilgrastim)*.

Support for patients with cancer

Supporting patients now and in the future

We continue to explore opportunities to expand into other treatments for cancer and other conditions associated with cancer like neutropenia. Our intent remains, as always, to provide patients with the most effective and safest treatments for their diseases.

Our work with patients, and our experience in this area of therapy, means we are really well placed to invest in extensive research into potential medicines to cure or help alleviate the many symptoms of cancer, to offer patients a wider choice of treatments.

* This medicine is subject to additional monitoring to allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects.